Halma plc 28.1% Potential Decrease Indicated by JP Morgan Cazenove

Broker Ratings

Halma plc with EPIC/TICKER (LON:HLMA) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘UNDERWEIGHT’ today by analysts at JP Morgan Cazenove. Halma plc are listed in the Industrials sector within UK Main Market. JP Morgan Cazenove have set a target price of 1420 GBX on its stock. This would indicate that the analyst believes there is a downside of -28.1% from today’s opening price of 1976 GBX. Over the last 30 and 90 trading days the company share price has increased 239.5 points and increased 334 points respectively. The 52 week high share price is 1986.5 GBX while the year low share price is currently 1215 GBX.

Halma plc has a 50 day moving average of 1,805.83 GBX and a 200 Day Moving Average share price is recorded at 1,523.51. There are currently 379,645,332 shares in issue with the average daily volume traded being 2,626,660. Market capitalisation for LON:HLMA is £7,503,271,800 GBP.

Share on:
Find more news, interviews, share price & company profile here for:
    Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy.
    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.
    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.

      Search

      Search